A Uzbek citizen has created an AI for early detection of health risks — now the startup is expanding into the global market

The team aims to shift medicine from a reactive model to a preventive one by combining symptoms, medical history, test results, and data from wearable devices. This article explains how the Sino AI idea emerged, why the startup considers its AI medical assistant its main product, and how the team plans to enter the Central Asian, Caucasus, and MENA markets.

Alisher Akmaljonov, city — Tashkent, CEO of Sino AI, LinkedIn

How It All Started

It all began with a family issue. I faced health problems among my parents, spouse, child, and other close relatives. That’s when the idea emerged to help people notice changes in their health status in a timely manner.

Sino AI’s mission is to help people learn about health risks before it becomes too late.

Startup Launch

We want to shift medicine from a reactive model to a preventive one. Therefore, we are creating a personal health profile that combines symptoms, medical history, test results, and daily metrics.

For monitoring, we use the Sino Band — a wearable bracelet that collects data on the body’s condition. In the future, we plan to integrate with WHOOP, Fitbit, Apple Watch, and other wearable devices.

AI analyzes all this data dynamically and helps track changes in a person’s condition over time.

The company’s main asset is not the device, but the AI medical assistant. WHOOP and Fitbit collect data from wearable devices, while K Health uses clinical AI. Sino AI aims to combine these capabilities into a single ecosystem that includes health monitoring, AI risk analysis, explanation of test results and diagnoses, and doctor appointment booking.

The Band is not the company’s main product. The core value lies in the AI assistant, which works with various types of data and becomes personalized.

Challenges

In HealthTech, being reliable is more important than being first. In medicine, development speed differs from other tech sectors. A quick launch cannot be more important than responsibility. The product must be innovative, scientifically grounded, clinically validated, and safe.

In the long term, we want to create a platform that users will trust daily and that clinics, insurance companies, and corporations can integrate into their processes.

Achievements

For us, it’s not just about the number of users, but the real value provided to their health. Company growth is measured not only by the number of registrations and users. It’s important to understand whether the product helps make timely decisions: was a risk detected, did the person undergo an examination, receive a diagnosis, or get the necessary help.

We track user retention, subscriptions, CAC, and LTV. But the main metric in HealthTech is how many people we helped detect a health problem in time.

Uzbek startups are already beginning to gain international recognition. The startup ecosystem in the country is developing, with more founders targeting the global market, while local accelerators, investment funds, IT Park Uzbekistan, and international initiatives help companies expand beyond the country.

In 2026, we received the AI in Healthcare Award at the ASOCIO Digital & AI Awards. For our team, this was an important confirmation that AI and HealthTech projects created in Uzbekistan can compete at the international level.

Plans

If I could change one thing, I would have started entering the global market earlier. Although we laid the foundation for our international strategy from the very beginning.

We are working with the Central Asian and Caucasus markets, and the next direction we are considering is MENA and other emerging markets. According to our estimates, the total addressable market is around $43 billion.

We want to build not just a successful startup, but a global business. It is important to me to show that technologies created in Uzbekistan can scale far beyond the local market and help millions of people.